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ApoptosisSindbis virus (SINV) induces inﬂammatory and vasoactive responses that are associatedwith rash and arthritis in
human infections. The mechanisms underlying infection-associated microvasculopathy are still unknown. We
investigatedwhether endothelial cells infected by SINV are differentially responsive to bradykinin (BK), a potent
inducer of inﬂammatory edema in a broad range of infectious diseases. Human endothelial cells (HBMECs)
infected with SINV presented an upregulation of bradykinin B2 receptors (BK2R) expression. Also, BK reduced
SINV-induced apoptosis and enhanced virus replication in HBMECs in a way dependent on BK2R, PI3 kinase
and ERK signaling. Strikingly, intracerebral infection of mice in the presence of a BK2R antagonist reduced the
local viral load. Our data suggest that SINV infection renders human endothelial cells hypersensitive to BK,
which increases host cell survival and viral replication. Ongoing studies may clarify if the deregulation of the
kinin pathway contributes to infection-associated vasculopathies in life-threatening arbovirus infections.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Sindbis virus (SINV), a prototype member of the Alphavirus genus,
is an enveloped, single-strand positive sense RNA virus (Strauss and
Strauss, 1994). In mice, SINV infection produces encephalitis and it
is considered a model to study the pathogenesis of human
arthropod-borne encephalitis caused by other alphaviruses (Johnson
et al., 1972; Lustig et al., 1988). Resistance to SINV infection in murine
models is age-dependent and involves the participation of multiple
mechanisms, such as neuronal maturation (Grifﬁn et al., 1994), varia-
tions in cytokine secretion and interferon-induced responses (Labrada
et al., 2002; Trgovcich et al., 1999), attenuation of the inﬂammatory
response (Ryman et al., 2007), and differential expression of pro and
anti-apoptotic genes (Grifﬁn, 2005; Grifﬁn et al., 1994; Labrada et al.,
2002). Noteworthy, apoptosis is often associated to central nervous
system (CNS) pathology (Kerr et al., 2002; Lewis et al., 1999; 4 SaridInstituto de Microbiologia Prof.
, Bloco I, Av. Carlos Chagas Filho,
-902. Fax: +55 21 2560 8344.
sevier OA license.et al., 2001), albeit it may also represent a cellular defense mechanism
to limit viral replication (Teodoro and Branton, 1997).
Although the mechanisms of virus-induced encephalitis are not
completely understood, there is strong evidence that it requires
leukocyte extravasation through the blood brain barrier (BBB) (Kim
et al., 2009). The BBB typically excludes circulating cells in normal
conditions, but there is evidence that the presence of SINV in the
brains of inoculated mice induces the activation of the endothelium,
leading consequently to the upregulation of adhesion molecules
(Irani and Grifﬁn, 1996). It was also showed that the expression of
these adhesion molecules in the BBB is modulated according to the
stage of SINV infection, being responsible for lymphocyte migration
to the central nervous system (CNS) (Irani and Grifﬁn, 1996).
In humans, SINV infectionmay cause fever, rash, and arthritis (Laine
et al., 2004). Viral arthritis is characterized by swelling, pain and leuko-
cyte inﬁltrate into the joint (Fraser, 1986), all of which are associated to
inﬂammatory alterations of the underlying endothelium. The mecha-
nisms governing pathogenic outcome and extent of SINV replication
in human cells are not sufﬁciently well characterized (Calabrese and
Naides, 2005).
Bradykinin-related vasoactive peptides, collectively called kinins,
are proteolytically derived sentinel mediators that are rapidly
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associated inﬂammation. Recent studies revealed that platelet-
derived polyphosphates may directly initiate proteolytic cascades de-
pendent on Factor XII (FXII), such as the intrinsic pathway (contact
system) of coagulation and the kallikrein–kinin system (KKS) (Van
der Meijden and Heemsherk, 2010). The autocatalytic cleavage of
FXII generates small amounts of FXIIa, which then converts prekallik-
rein into active plasma kallikrein, a serine protease that ampliﬁes the
contact system through the reciprocal activation of FXII into FXIIa.
As the ampliﬁcation loop progresses, plasma kallikrein releases
bradykinin (BK) from an internal segment of high molecular weight
kininogen. Once released in the bloodstream, the short-lived BK acts
as paracrine hormone, inducing vasodilation in arterioles via produc-
tion of nitric oxide (NO), through the stimulation of bradykinin B2
receptor (BK2R) constitutively expressed in the endothelium. BK may
then be further metabolized in the bloodstream by carboxypeptidase
N (kininase 1), thereby generating des-Arg-bradykinin (des-Arg-BK).
As opposed to the BK2R agonist, des-Arg-BK triggers the kinin B1 recep-
tor (BK1R), a GPCR subtype that is induced in inﬂamed tissues (Austin
et al., 1997; Bhoola et al., 1992; Menke et al., 1994). In other settings,
BK is known to trigger a broad spectrum of biological responses, includ-
ing cellular proliferation and rescuing from apoptosis, observed after
renal, cardiac and brain injuries (Bledsoe et al., 2006; Xia et al., 2004).
Molecular analysis of the intracellular pathways controlled by BK2R
revealed that BK can induce cAMP formation (Regoli et al., 1990),
activation of PI3K-phospho-Akt pathway and p42/p44MAPK (Bovenzi
et al., 2010; Greco et al., 2006), and upregulation of anti-apoptotic
mediators in endothelial cells (Bovenzi et al., 2010).
Recent progress in microbial immunity provided clues to under-
stand how activation of the kinin systemmay modulate inﬂammation
and immunopathogenesis of numerous infectious diseases, including
bacteria, protozoan and virus infections (Christiansen et al., 2008;
Folkerts et al., 2000; Kaman et al., 2009; Monteiro et al., 2007,
2009). Respiratory syncytial virus (RSV), inﬂuenza, and other respira-
tory viruses increase local kinin levels and kinin receptor expression,
these effects being associated to increased severity of clinical symp-
toms (Barnett et al., 1990; Bengtson et al., 2007; Naclerio et al.,
1988). Although not directly related to KKS, there is evidence that
HIV infections enhance Substance P expression in immune cells,
which increases virus replication (Ho et al., 2002; Li et al., 2001), thus
setting an interesting precedent for the studies involving the KKS.
It was previously reported that activation of BK2R by BK is involved
in inﬂammatory processes related to arthropathies and that BK2R
antagonist may inhibit carrageenan and lipopolysaccharide (LPS)-
induced arthritis in rat by reducing joint pain, edema and neutrophil
inﬁltration (Valenti et al., 2010). Also, kallikrein inhibitors, such as
kallistatin are associated to a protective effect in rat arthritis model
(Wang et al., 2005). Although Alphavirus infection causes alterations
in vascular permeability and cell survival modulation, the possibility
that kinins may inﬂuence pathogenic outcome was not the object of
systematic studies.
Except for studies with non-replicating SINV vectors (Tseng et al.,
2004; Wollmann et al., 2005) and few reports of infection of human
macrophages or PBMCs (Assunção-Miranda et al., 2010; Dhanushkodi
et al., 2011) little efforts were invested in characterizing the molecu-
lar mechanisms regulating SINV infection in human cells. Here, we
analyzed if human endothelial cells were permissive to SINV infection
and evaluated whether BK signaling wouldmodulate virus replication
and cellular apoptosis. We observed that SINV induced an upregula-
tion of BKRs on human brain microvascular endothelial cells
(HBMECs). In addition, we observed that signaling of BK2R increases
HBMECs permissiveness to infection by promoting a delay in the
virus-induced apoptosis. Extending these studies to the context of in
vivo infection, we obtained evidences that it is possible to reduce
acute viral load in the CNS through the local administration of HOE-
140, a speciﬁc antagonist of BK2Rs.Results
Human brain microvascular endothelial cells upregulate kinin receptors
upon infection by Sindbis virus
The endothelium plays a central role in the pathogenesis of Sindbis
virus infection. However, the direct interaction of endothelial cells
with the virus was not evaluated before. We investigated whether
endothelial cells would be a target for SINV infection in vitro. HBMECs
were infected with SINV at an MOI of 0.1 and the supernatants were
titrated by plaque assay after different time points. Virus titers released
in the supernatants increased over time, suggesting a productive infec-
tion of these cells. The peak of virus detection was observed at 36 h p.i.
and virus titers decreased thereafter (Fig. 1A). Consistent with these re-
sults, RT-PCR showed the presence of viral genome in the cell lysates
and supernatants of HBMECs (Fig. 1B). The expression of viral proteins
in infected cells was conﬁrmed by immunoﬂuorescence and ﬂow cyto-
metry analysis (Figs. 1C and D).
After showing that HBMECs are susceptible to SINV, we sought to
determine whether the viral infection could inﬂuence endothelium
sensitivity to vasoactive kinin. To this end, we compared the expres-
sion proﬁle of BK2R and BK1R in normal and SINV-infected HBMECs
by quantitative real-time PCR. Assays performed 24 h p.i. revealed
that SINV infection induced an increase of 3.7 and 23.8 fold in BK2R
and BK1R transcription, respectively, as compared to the non-infected
HBMECs, which displayed low levels of such transcripts (Fig. 2A).
FACS analysis showed that the transcriptional upregulation observed
in SINV-infected HBMEC translated into a modest increase in the
percentage BKR-expressing cells and in the magnitude of BKR expres-
sion (mean ﬂuorescence intensity-MFI) (Fig. 2B). Control experiments
showed that transcription or surface expression of both BKRs was not
signiﬁcantly modulated in HBMECs mock-infected or treated with
heat-inactivated virus (Figs. 2A and B).
We then compared BKR surface expression between the subpopu-
lations of infected and bystander cells (Fig. 2C). The results revealed
that increased BK2R and BK1R expressions were mostly related to
SINV-infected (SINV+) cells. Fig. 2C demonstrated that 58.6% and
56% of all SINV+ (5.39% and 7.32% total) express BK2R and BK1R,
respectively. In contrast, only 22.17% and 21.9% (20.13% and 18.99%
total) of SINV− cells express the receptors, similar to what was
observed in noninfected cultures (mock). Inactivated virus did not
affect BKR expression. We also observed a higher MFI of BKR surface
expression in SINV-infected cells than in non-infected HBMECs
(36.88 SINV+ vs 9.60 SINV− for BK2R; 54.72 SINV+ vs 11.59 SINV−;
data not shown). Taken together, mRNA and protein expression
data support that SINV infection indeed upregulated BKR expression.
Bradykinin increases SINV replication in a BK2R-dependent way
Given evidences that endothelial cells infected by SINV upregulate
BKRs, we then investigated the inﬂuence of BK-induced signaling on
virus replication. To this end, HBMECs were exposed, or not, to phys-
iological concentrations of BK (10 nM) and virus replication was
analyzed. These assays were performed in the presence of the ACE
inhibitor lisinopril (ACEi) in order to prevent BK degradation by this
metallopeptidase, which is highly expressed in endothelial cells, such
as HBMECs. Our results showed that addition of ACEi/BK simultaneous-
ly to SINV did not inﬂuence the progression of infection (Fig. 3A). Strik-
ingly, however, the virus load was signiﬁcantly increased when the
HBMECs were treated with BK 24 h after viral exposure (Fig. 3A), i.e.,
coinciding with the time point when BKRs are upregulated. Additional
experiments showed that BK stimulated viral replication in dose-
dependent manner (Fig. 3B). Of note, addition of the ACEi alone did
not signiﬁcantly increase the viral load (Fig. 3C), suggesting that block-
ade of angiotensin I production per se is not sufﬁcient to increase
HBMEC susceptibility to SINV. These results suggested that the ACEi
Fig. 1. Human brain microvascular endothelial cells are permissive to in vitro infection by SINV. HBMECs were cultured with SINV at a MOI 0.1 or with supernatant of non infected
VERO cells (mock) and the infection was evaluated by different methods. A) Time course of HBMECs infection evaluated by plaque assay. B) After 48 h p.i. the cells and supernatants
were harvested and viral RNA present in both fractions was ampliﬁed by RT-PCR. C) After 48 h p.i. the cells were ﬁxed, permeabilized and stained with mouse anti-SINV antibody
followed by anti-mouse IgG conjugated to AlexaFluor 546. The slides were then analyzed by ﬂuorescence microscopy. D) After 48 h p.i., the cultured cells were harvested and
stained as in (C) and were analyzed by ﬂow cytometry. M1 indicates the percentage of SINV+. The data are representative of two independent experiments.
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signaling of BKRs (Fig. 3C). Therefore, we performed all subsequent
experiments in the presence of ACEi.
As an extension of these studies, we checked whether BK-induced
increase in viral load was neutralized by speciﬁc antagonists of BKRs.
Indeed, we found that HOE-140, a selective inhibitor of BK2R, abro-
gated BK-induced increase of viral replication (Fig. 3D). In spite of
the increased expression of BK1R, addition of its speciﬁc antagonist
([Leu8]-desArg9-BK) did not signiﬁcantly reduce virus replication
(Fig. 3E). Consistent with these data, the addition of des-Arg-BK
(i.e., BK1R agonist) did not increase SINV titers (data not shown).
We then repeated these assays using primary cultures of human
umbilical vein endothelial cells (HUVECs). Similarly to HBMECs, BK
addition enhanced SINV replication in HUVECs, whereas HOE-140
blocked these effects (Fig. 3F). Collectively, these results suggested
that BK increased the permissiveness of endothelial cells to SINV
through the signaling of the BK2R.
Bradykinin inhibits SINV-induced apoptosis
SINV infection has been reported to induce cell death in CNS
murine cells and in human macrophages (Assunção-Miranda et al.,
2010; Grifﬁn, 2005; Irusta and Hardwick, 2004). Apoptosis is an
event usually observed at a late time point after virus infection and
is considered to be a mechanism to control virus dissemination (Lee
et al., 2005; Teodoro and Branton, 1997). Given that BKR engagementis associated to cell signaling pathways involved in rescuing cells
from apoptosis (Bledsoe et al., 2006; Xia et al., 2004), we reasoned
that perhaps BK boosts viral replication because it prolongs survival
of SINV-infected cells through the induction of anti-apoptotic path-
ways. In order to explore this issue, we ﬁrst checked if SINV was
also inducing cell death in HBMECs. Analysis by MTT assay (Fig. 4A)
and neutral red staining (not shown) demonstrated a decrease in
the proportion of live HBMECs after SINV infection, which was statis-
tically signiﬁcant at 36 h p.i. and thereafter. Of note, inactivated SINV
failed to induce cell death (Fig. 4A). We then analyzed whether BK,
added 24 h after the onset of infection, could rescue HBMECs from
cell death. The results showed that addition of BK 24 h p.i. inhibited
cell death, at least in the ﬁrst 12 h (end point 36 h p.i.). These effects
were no longer observed when we run MTT assays at 48 h p.i.
(Fig. 4B). Also, inhibition of virus-induced cell death could be
detected even when BK was added in the absence of ACEi, suggesting
that the effect mediated by ACEi in some experiments resulted from
inhibition of endogenous BK present in the cell culture. These results
suggested that BK2R signaling within the narrow window (24 to
36 h) is sufﬁcient to create a window of opportunity for viral growth
in HBMECs.
In order to determine if the observed cell death could be attribut-
ed to apoptosis, we infected HBMECs and double stained them with
propidium iodide (PI) and AlexaFluor488-Annexin V. Assessment of
the percentage of live (AnexV−PI−), dead (AnexV−PI+) or apoptotic
(either AnexV+PI or AnexV+PI+) cells revealed that there was a
Fig. 2. SINV infection upregulates the expression of BK receptors. HBMECs were mock-infected or cultured with infective (SINV) or heat-inactivated SINV (iSINV) with an MOI of 0.1
and the expression of BK1R and BK2R was evaluated by different methods. A) Total cellular RNA was extracted 24 h p.i. and subjected to quantitative real-time PCR, using speciﬁc
commercial assays for B1 or B2 receptors. B) After 24 h p.i., the cells were harvested and stained with anti-BK1R or anti-BK2R antibodies, followed by staining with anti-rabbit IgG
conjugated to PE. The expression of B1 and B2 receptors in the cell surface was evaluated for ﬂow cytometry. The results are expressed as the percentage of cells expressing the
receptors (% cells) or as mean ﬂuorescence intensity (MFI). C) After 24 h p.i., the cells were harvested, stained as in (B), and then permeabilized and incubated with anti-SINV an-
tibody, followed by incubation with anti-mouse IgG antibody conjugated to AlexaFluor 488. The cells were analyzed by ﬂow cytometry and the ﬁgure is a representative quadrant
plot of SINV vs BK2R or BK1R staining. Insert numbers express the percentage of cells in each quadrant. The data are representative of three independent experiments and error bars
indicate SD values between replicates in all experiments. * p≤0.05 in relation to the mock.
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at 36 h p.i., which was reverted upon addition of BK in preceding 12 h.
We did not observe any statistical difference between BK-treated and
untreated HBMECs infected cells at 48 h p.i. (Fig. 4C). To further test
the hypothesis that BK could be inhibiting apoptosis, we performed
FACS analysis of SINV-infected HBMECs at 36 h p.i. (12 h after BK stim-
ulation), using a PI-containing hypothonic ﬂuorochrome solution,
which binds the cellular DNA, thereby allowing the analysis of cell
cycle phases and the determination of the frequency of apoptotic cells.
Again, we observed that HBMECs treated with BK (in the presence orabsence of ACEi) underwent decreased apoptosis. Of note, addition of
HOE-140 reverted the BK-induced rescuing of apoptosis (Fig. 4D), sug-
gesting that delayed apoptosis may account for the enhanced virus rep-
lication observed in BK-treated HBMECs.
BK-driven modulation of viral replication and apoptosis is dependent on
PI3K activation
Cell survival induced by BK2R engagement is usually related to ac-
tivation of the PI3 kinase (PI3K) and phosphorylation of either Akt
Fig. 3. BK increases viral replication in HBMECs infected cells in a BK2R-dependent path-
way. A) HBMECs were infected with SINV (MOI=0.1) and treated at the indicated time
points with bradykinin (10 nM), after a pretreatment with the ACE inhibitor lisinopril
(25 μM). After 48 h p.i., virus titers in the supernatants were evaluated by plaque assay.
B) HBMECs were infected with SINV (MOI=0.1) and, 24 h later, the cells were treated
with ACEi/BK at the indicated concentrations. Virus titers in the supernatants were evalu-
ated byplaque assay at 48 h p.i. C) HBMECswere infectedwith SINV (MOI=0.1) and, 24 h
later, the cells were treated with either BK or ACEi, or with both stimuli (ACEi/BK). After
24 h post stimuli (48 h p.i.), the culture supernatants were harvested and viral replication
was evaluated by plaque assay. D–E) HBMECswere infected and treated with ACEi/BK (at
24 h p.i.), in the presence or absence of the B2 receptor antagonist — HOE-140 (100 nM)
(D) or B1 receptor antagonist — [Leu18]desArg9BK (100 nM) (E). Viral replication was
analyzed at 48 h p.i. by plaque assay. F) HUVECs were infected with SINV and treated as
described in (D). Viral replication was evaluated at 48 h p.i. by plaque assay. The data
are representative of ﬁve independent experiments and error bars indicate SD values
between replicates in all experiments. * p≤0.05 and # p≤0.1 when comparing to SINV
alone; ** p≤0.05 and ## p≤0.1 when comparing to BK-treated.
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Prado et al., 2002; Penna et al., 2008). To investigate the role of
these signaling pathways in the BK-induced modulation of virus rep-
lication and cell survival, HBMECs were infected and treated with BK,
in the presence or absence of the PI3K inhibitor wortmannin
(100 nM). Addition of wortmannin to BK-treated cultures abrogated
both effects mediated by the BK peptide (Figs. 5A and B). These data
indicate that BK2R signaling induces increased cell survival and
virus replication through the activation of PI3K.
We also performed kinetics experiments to investigate the effect
of SINV infection and BK treatment on the PI3K-driven activation re-
sponses. Infection of HBMECs resulted in a transitory increase of Akt,
which peaked at 24 h p.i. and decayed thereafter. In addition, SINV in-
duced an earlier phosphorylation of ERK (1 h p.i.), which decayed at
10 h p.i. We then examined the effects of BK added 24 h p.i. Our re-
sults showed that BK upregulated pERK, but not pAKT, at 36 h p.i.
(12 h after BK addition) (Figs. 6A and B). Modulation of Akt phos-
phorylation was not observed even at earlier or later time points
(data not shown), suggesting that activation of ERK MAPK may be
involved in BK/PI3K-mediated cell survival and enhanced viral repli-
cation. Indeed, similar to HOE-140 and wortmannin, addition of theERK inhibitor PD98059 abolished BK-mediated increased cell survival
and virus replication in HBMECs (Figs. 7A and B).
Blocking BK2R inhibits SINV replication in the CNS in vivo
In order to investigate the in vivo relevance of the observations
made in tissue culture conditions, BALB/c mice were infected i.c.
with a suspension of SINV (5×104 PFU) containing, or not, the
BK2R antagonist HOE-140. Analysis of the viral load in the brain
(24 h p.i.) revealed that HOE-140 signiﬁcantly reduced the virus
titer in the CNS (Fig. 8). These results suggest that SINV infection
may be enhanced as result of KKS activation in the in vivo settings.
Discussion
In the present work, we tested the hypothesis that BK, the short-
lived vasoactive peptide generated by activation of the KKS, may inﬂu-
ence the susceptibility of human endothelial cells to infection by Sindbis
Alphavirus. The rationale to undertake this study was based on a prece-
dent that kinins can induce vasodilatation, vascular permeability, cyto-
kine secretion and inhibition of apoptosis of different cell types,
including endothelial cells (Aliberti et al., 2003; Bhoola et al., 1992;
Bovenzi et al., 2010; Prado et al., 2002; Yin et al., 2005), being therefore
capable of contributing to the pathogenesis of infections caused by
arbovirus, such as Sindbis. Knowledge about the pathogenetic mecha-
nisms underlying SINV pathogenesis is still limited to studies in exper-
imentally infected mice (Grifﬁn et al., 1994; Kerr et al., 2002; Ryman et
al., 2007). Pertinent to the present work, the encephalitis described in
the SINV-infected mice is associated to extravasation through the BBB
(Irani and Grifﬁn, 1996). In addition, it has been reported that
alphavirus-induced arthritis observed in humans is associated with
leukocyte inﬁltrate into the joint (Fraser, 1986), whichmay be a conse-
quence of altered vascular leakage and endothelial cell activation. Thus,
there is substantial evidence that endothelium dysfunction contributes
to SINV infection-associated vasculopathy, both in mice and humans.
Except for a few studies with glioma cell lines and primary macro-
phages and PBMCs (Assunção-Miranda et al., 2010; Dhanushkodi et
al., 2011; Wollmann et al., 2005), the analysis of the outcome of
SINV infection of human cells involved studies with nonreplicating
vectors (Tseng et al., 2004; Wollmann et al., 2005). Despite the
cited indications that SINV infection leads to endothelial cell dysfunc-
tion, there were no systematic attempts to determine if the formation
of proinﬂammatory mediators may inﬂuence endothelial cell permis-
siveness to SINV infection.
In the present report, we demonstrated that human brainmicrovas-
cular endothelial cells (and primary endothelial cells) were permissive
to SINV infection in vitro. Our results showed that B1 and B2 bradykinin
receptors were upregulated upon endothelial cell infection, increasing
their sensitivity to signaling by BK. Notably, there was a signiﬁcant
BK2R-dependent increase in virus replication upon addition of BK
24 h p.i., coinciding with the period of maximal BK receptor expression.
Regulation of kinin generation or kinin receptor expression has
been previously observed during RNA virus infections, however, in
these studies these events were mainly associated to the inﬂammato-
ry response (Barnett et al., 1990; Christiansen et al., 2008; Folkerts et
al., 2000; Proud et al., 1990; Tripp et al., 2000). Human and bovine
rhinovirus (hRSV and bRSV) infections resulted in increased local for-
mation of kinins, the severity of clinical disease being correlated with
the level of kinins detected in respiratory secretions (Naclerio et al.,
1988; Proud et al., 1990). Interestingly, double strand RNA surrogates,
like poli I:C, also upregulated the expression of BK1R and BK2R, there-
fore suggesting that activation of innate immune receptors, such as
Toll like receptor 3 (TLR3) or RIG-I/MDA5 may upregulate BKR ex-
pression (Bengtson et al., 2007). In preliminary studies, we observed
that infection of endothelial cells by ﬂaviviruses also induced an upre-
gulation of BK receptors, suggesting that it may represent a more
Fig. 4. BK inhibits SINV-induced cell death. A) HBMECs were mock-infected or cultured with infective (SINV) or heat-inactivated SINV (iSINV) with a MOI of 0.1 and cell viability was
evaluated by MTT assay at different time points p.i. B) HBMECs were infected with SINV and, 24 h later, the cells were treated with BK, ACEi or both stimuli (ACEi/BK). After 36 and
48 h incubation, cell viability was evaluated by MTT assay. The data were normalized according to the results obtained with the cells cultured with culture medium only (adjusted to
100%). C) The cells were double stained with propidium iodide (PI) and AlexaFluor488-Annexin V. The percentage of live (PI−/Annex−), dead (PI+/Annex−) or apoptotic (PI−/
Annex+, and PI+/Annex+) cells were analyzed by ﬂow cytometry at 36 and 48 h p.i. D) HBMECs were cultured as in (B). After 36 h p.i. (12 h post stimuli), the cells were incubated
with hypotonic ﬂuorochrome solution and apoptosis was analyzed by ﬂow cytometry. The results indicate the percentage of apoptotic cells. The data are representative of three indepen-
dent experiments and error bars indicate SD values between replicates in all experiments. * p≤0.05 when comparing to mock-infected; **p≤0.05 when comparing to SINV-infected;
*** p≤0.05 when comparing to BK-treated; # p≤0.1 when comparing to mock-infected.
Fig. 5.Modulation of viral load and apoptosismediated by BK is dependent onPI3K activation. HBMECswere infectedwith SINV (MOI=0.1) and, after 24 h p.i., the cellswere treatedwith
BK (10 nM), in the presence or absence of the wortmannin (wort, 100 nM). A) 36 h p.i the cells were harvested and incubated with PI and AlexaFluor488-Annexin V. The percentage of
apoptotic cells was evaluated by ﬂow cytometry. B) 48 h p.i., the culture supernatants were collected and viral titers were evaluated by plaque assay. The data are representative of three
independent experiments and error bars indicate SD values between replicates in all experiments. *p≤0.05 when comparing to mock-infected; ** p≤0.05 when comparing to SINV-
infected; *** p≤0.05 when comparing to BK-treated.
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Fig. 6. Modulation of AKT and ERK phosphorylation mediated by SINV infection and BK
treatment. HBMECswere infectedwith SINV (MOI=0.1) ormock control for the indicated
time points. At 24 h p.i. the cells were stimulated with BK, in the presence or absence of
wortmannin (wort; 100 nM) or PD98059 (PD; 30 μM), as indicated. The cells were lysed
at the indicated time points and whole-cell lysates were loaded onto SDS-PAGE gels.
Blot were run and probed with anti-phospho Akt antibody (pAkt) (A) or with anti-
phospho ERK antibody (p44/p42) (B). The blots were also probed with anti-b-actin
or a-tubulin as a load control. Bar graphics show the ratio of phosphorylated kinases
and constitutive proteins. The data are representative of three independent
experiments.
Fig. 8. BK2R blocking inhibits SINV replication in the CNS in vivo. BALB/c mice were pre-
treated with captopril (ACE inhibitor, 100 mg/kg) for 1 h and then inoculated with SINV
(5×104 PFU, i.c.), with or without HOE-140 (100 mg/kg). After 24 h of infection, the
animals were sacriﬁced, the brains were harvested and the viral load was quantiﬁed by
plaque assay. Results are shownas the number of PFUper g tissue. Dots represent individual
animals from one of two independent experiments showing similar data.
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(unpublished data).
Beyond the effects on BK-sensitivity of SINV-infected cells, there is
a precedent that HIV infection enhances Substance P expression in
immune cells (Ho et al., 2002), which then increases virus replicationFig. 7. Increased viral replication and diminished apoptosis mediated by BK is dependent on
were treated with BK (10 nM), in the presence or absence of the ERK inhibitor PD9805
AlexaFluor488-AnnexinV and the frequency of apoptotic cells was evaluated by ﬂow cytom
sured by plaque assay. The data are representative of three independent experiments and e
paring to mock-infected; ** p≤0.05 when comparing to SINV-infected; *** p≤0.05 when cin latently infected human immune cells (Li et al., 2001). Moreover,
bRSV produces a peptide (p27), which is released from infected
cells and is further posttranslationally modiﬁed and converted into
virokinin a member of the tachykinin family (Zimmer et al., 2003).
Calves infection with a p27-deﬁcient bRSV showed diminished virus
titer in different tissues (Valarcher et al., 2006), demonstrating that
kinin-mediated signals can enhance virus replication.
Cellular apoptosis following viral infection is considered as a host
defense mechanism, since it limits virus production and prevents
neighboring cells from being infected by progeny virions (Teodoro
and Branton, 1997). Thus, most animal viruses have evolved strate-
gies to evade or delay early apoptosis. This can be achieved by the
generation of virus-coded anti-apoptotic proteins or, more often, by
inducing or stimulating endogenous anti-apoptotic cellular pathways
(Lee et al., 2005; Roulston et al., 1999). Conversely, several viruses ac-
tively induce apoptosis at late stages of infection, thus allowing the
dissemination of progeny viruses, while avoiding host inﬂammatory
and immune responses (Levine, 2002; Teodoro and Branton, 1997).
It was previously reported that ﬂaviviruses induce the activation
of the anti-apoptotic PI3K/Akt pathway early during infection; this
process is inhibited at late stage of infection, allowing for cellular ap-
optosis and enhancing virus-induced cell death (Lee et al., 2005). This
mechanismmay also occur in SINV infection, since it was demonstrat-
ed that the infection of mosquito cells with recombinant SINV expres-
sing proapoptotic genes turns a persistent infection into a lytic
process. As a consequence of this manipulation, virus production
was subsequently decreased compared to persistently infected cells,
which continued to produce high levels of virus over the next several
days (H. Wang et al., 2008).
BK2R signaling of muscle and endothelial cells results in increased
nitric oxide production, cAMP upregulation, PKB/Akt phosphorylation,ERK activation. HBMECs were infected with SINV (MOI=0.1) and 24 h later, the cells
9 (PD; 30 μM). A) At 36 h p.i. the cells were harvested and incubated with PI and
etry. B) At 48 h p.i. the culture supernatants were harvested and viral titers were mea-
rror bars indicate SD values between replicates in all experiments.*p≤0.05 when com-
omparing to BK-treated.
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2002). These effects are mainly dependent on PKA or PI3K activation
and resulted in several phenotypic changes, such as increased cell sur-
vival and inhibition apoptosis (Bledsoe et al., 2006; S. Wang et al.,
2008; Roberts et al., 2004; Yao et al., 2008; Yin et al., 2005). Based on
our ﬁndings, we hypothesized that conditions leading to excessive
activation of the KKS, perhaps associated to FXII-dependent activation
of the contact system, may generate high levels of BK in the blood-
stream of SINV-infected patients. If extrapolated to the in vivo settings,
our data suggest that activation of BKR may sustain anti-apoptotic
responses extended periods, keeping the cells alive, thus ultimately
favoring viral replication. Interestingly, signiﬁcant levels of death/
apoptosis in non treated infected cultures started to be observed at
the peak of virus replication (36 h p.i.). The number of dead/apoptotic
cells increased further on, coinciding with a decrease in the viral load.
Addition of BK after 24 h of infection resulted in a delay of cell
death/apoptosis, which was only observed at 48 h, probably reﬂecting
the enhanced virus replication observed at this time point. Conversely,
we found that the addition of HOE-140 or wortmannin reversed the
increase in cellular survival and virus replication induced by BK, sug-
gesting that BK2R is the upstream signal transducer inducing PI3K
activation.
PI3K activation may stimulate phosphorylation of Akt and ERK
MAPK, and both pathways are involved in rescuing cells from apoptosis
(Aksamitiene et al., 2011; Harris et al., 2001; Krieg et al., 2004; Prado et
al., 2002; Zhang et al., 2011). We observed that SINV infection induced
the phosphorylation of both Akt and ERK at early time points p.i. and
this phosphorylation was decreased later on. Therefore, the addition
of BK may prolong one or both signal pathways, allowing the endothe-
lial cells to live longer. Infected cells treated with BK showed sustained
pERK levels at 36 h p.i., but the samewas not observed for Akt. Also, ad-
dition of a pERK inhibitor to the cultures reversed apoptosis inhibition
and virus replication enhancement induced by BK, indicating that ERK
may act further downstream from PI3K in our cellular system. A similar
pathwaywas recently observed in other studies showing that activation
of PI3K can result in ERK phosphorylation and increased cell survival/
proliferation in a way independent on pAkt (Aksamitiene et al., 2011).
Virus infections are usually associated to vascular leakage that leads
to the release of relatively high concentrations of severalmediators that
may be involved in vascular permeability, including histamine, prosta-
noids (Chatuverdi et al., 1991), and possibly bradykinin as well. In this
context, it will be interesting to know whether SINV infection might
lead to platelet activation, perhaps allowing for polyphosphate-driven
generation of kinins in vivo. Although not directly addressed in our
study, vascular leakage may contribute to the extravasation of cells
and soluble mediators through BBB that are observed during SINV-
mediated encephalitis in mice (Irani and Grifﬁn, 1996). Also, even
though CNS involvement is not a clinical feature of human SINV infec-
tion, it is conceivable that plasma extravasation plays an underlying
role in the progression of arthritis and rash (Heitsch, 2000; Jaffar-
Bandjee et al., 2009), which are common sequels of inﬂammation in
the human SINV infection (Laine et al., 2004). Interestingly, a kallikrein
inhibitor, kallistatin, has been described to inhibit arthritis in a rat
model (Chai et al., 1993; Wang et al., 2005), suggesting that inhibition
of bradykinin generation in extravascular tissues may likewise attenu-
ate viral-induced arthritis.
In order to evaluate whether our in vitro results might have in
vivo relevance, we inoculated mice with SINV in the presence of the
BK2R inhibitor HOE-140. Our data showed that the prevention of
BK2R signaling by the speciﬁc antagonist resulted in a diminished
viral titer in the CNS. These data suggest that BK2R activation by
endogenous BK also increases SINV replication in vivo. As already
discussed, the protective effects mediated by the BK2R antagonist
may result from blockade of anti-apoptotic pathways induced by
BK, ultimately favoring the progression of virus infection in permis-
sive endothelial cells. Alternatively, the BK2R blocker may havecurbed BK-induced maturation of dendritic cells (Aliberti et al.,
2003), perhaps hampering the link between inﬂammatory edema
and BK2R-driven induction of type-1 effector T CD4+ and T CD8+
cells, as recently demonstrated in mice infected by two intracellular
pathogens, the intracellular protozoan Trypanosoma cruzi and the
Gram-negative periodontal bacterium Porphyromonas gingivalis
(Monteiro et al., 2007, 2009). Admittedly, additional studies are re-
quired to determine if BK2R-driven induction of anti-viral immunity
may enhance resistance to intracerebral SINV infection in this mouse
model.
In conclusion, we have reported that BK-induced activation of
human endothelial cells increase SINV viral load through the activation
of BK2R-driven anti-apoptotic responses. The observation that SINV-
infected endothelial cells upregulate BK2R, which in turn render the
cells hypersensitive to BK, provides a mechanistic basis to investigate
the potential inﬂuence of KKS regulation on the pathogenic outcome
of infection-associated vasculopathy caused by a wide range of RNA
virus.
Materials and methods
Cells and virus
Human brain microvascular endothelial cells (HBMEC), a generous
gift from Dr. Dennis J. Grab (The Johns Hopkins University, MD, USA),
have been previously described (Nikolskaia et al., 2006). This is a cell
line derived from primary human BMECs and immortalizedwith a plas-
mid containing the simian virus 40 large-T antigen (Stins et al., 1997).
The cells were cultured in medium 199 (M199) supplemented with
10% inactivated fetal calf serum (FCS — Invitrogen, Carlsbad, CA) and
antibiotics (Sigma Chem Co; St Louis, MO) (complete medium).
VERO cells were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM) (Invitrogen, Carlsbad, CA) supplemented with 5% inactivated
FBS. Human umbilical vein endothelium cells (HUVEC, gently provided
by Dr. Verônica Morandi, UERJ, RJ, Brazil) were cultured in M199
supplemented with 10% inactivated FCS and antibiotics.
The Malaysian MRE16 strain of Sindbis virus (SINV; Sammels et
al., 1999) was a gift from Dr. Andréa Thompson DaPoian (IBqM,
UFRJ, RJ, BR). SINV was propagated in VERO cells for 5 days, harvested
and stored at−80 °C until use. Virus titer was determined by plaque
assay using VERO cells. Virus inactivation was obtained after heating
at 56° for 30 min and was conﬁrmed by plaque assay and RT-PCR in
VERO cells.
Cell infection and stimulation
The cells were incubated with SINV, at a multiplicity of infection
(MOI) of 0.1, for 90 min at 37 °C in 5% CO2 atmosphere. As a control,
the cells were incubated with either supernatant of noninfected VERO
cells (mock-infected) or heat-inactivated SINV (iSINV). Cells were,
then, washed with phosphate buffer saline (PBS) and cultured with
complete medium. In some experiments, the cells were also treated
with 10 nM bradykinin (BK) (Calbiochem, Sigma, Saint Louis, MO) or
des-Arg-bradykinin (des-Arg-BK) (Sigma, Saint Louis, MO), after a
30 minute preincubation with lisinopril (25 μM) (Sigma, Saint Louis,
MO), an inhibitor of the angiotensin converting enzyme (ACE), herein
referred as ACEi. The antagonists of BK2R, HOE-140 (Aventis Pharma-
ceuticals, NJ, EUA), or of BK1R, [Leu8]des-Arg9-BK (Sigma, Saint Louis,
MO), and the PI3K inhibitor wortmannin (Sigma, Saint Louis, MO)
were added at a concentration of 100 nM. The pERK inhibitor,
PD98059 was used at a concentration of 30 μM. The antagonists and in-
hibitorswere added 30 min before the addition of the BKor des-Arg-BK,
when indicated.
The cells and supernatants were harvested 48 h after beginning of
the culture and virus infection was analyzed by plaque-forming assay,
immunoﬂuorescence, ﬂow cytometry or RT-PCR.
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HBMECs or HUVECs were infected and treated or not with the
peptides (BK or des-Arg-BK) at different time points after infection,
as indicated. After 48 h of infection, the supernatants were harvested
and serial dilutions were inoculated in VERO cells. After 60 min of
incubation at 37 °C, the inoculum was substituted for 500 μl of
carboxymethilcelulose 3%. The cells were incubated for seven days
at 37 °C in 5% CO2 atmosphere and, then, ﬁxed with 10% formalde-
hyde for 2 h and stained with 0.04% violet crystal for 10 m. The
number of plaque forming units (PFU) was determined and titers
were expressed as PFU per milliliter.
Virus detection by RT-PCR
HBMECs cells (106 cells/well) were infected and treated as de-
scribed. After 48 h p.i. the supernatants and cells were harvested and
RNA extracted using Trizol Reagent (Invitrogen, Carlsbad, CA), accord-
ing to themanufacturer's protocol. Total RNA (5 μg)was reversely tran-
scribed to cDNA using High-Capacity cDNA Archive Kit (Applied
Biosystems, CA, USA) using the following reaction parameters: 25 °C
for 10 min, 50 °C for 50 min, 85 °C for 5 min and chilled on ice. PCR
was carried out using the Gene Amp PCR System 9700 (Applied Biosys-
tems, Foster City, CA, USA). The reactions included 2 μl of cDNA, primers
(20 μM each), TaqMan Universal PCR Master Mix (Applied Biosystems,
Foster City, CA, USA) and water added to a ﬁnal volume of 25 μl. The
sequences of SINV primers used were 5′tgt.aaa.cca.cca.gct.gac.ca3′, as
the sense primer, and 5′cac.cac.gct.tcc.tca.gaa.at 3′ as antisense,ﬂanking
a 426 bp sequence located at E1 region (Assunção-Miranda et al., 2010).
Cycle conditionswere as follows: after an initial 2-min hold at 95 °C, the
samples were cycled 45 times at 95 °C for 30 s, 55 °C for 30 s and 72 °C
for 1 min.
Analysis of SINV infection by immunoﬂuorescence and ﬂow cytometry
HBMECs (106 cells/well) were infected with SINV for 48 h, as
described. The cells were harvested, ﬁxed with 4% paraformaldehyde
for 10 min, and blocked with PBS containing 4% normal mouse serum
and 0.1% saponin. The cells were then incubated with mouse anti-
SINV (a kind gift from Dr. Andrea T. DaPoian) for 1 h, washed and
stained with anti-mouse IgG conjugated to Alexa ﬂuor-488 (Invitrogen,
Carlsbad, CA) for 30 min. The percentage of SINV+ cells were evaluated
by ﬂow cytometry using a FACScalibur cytometer (Becton Dickson
Immunocytometry System). Events (10,000) were acquired and were
analyzed using the CellQuest software. Alternatively, the cells were
seeded onto coverslips, which were stained as described, and mounted
onto glass slides using ProLong Antifade reagent (Molecular Probes,
Eugene, OR). HBMECs infection was then analyzed by ﬂuorescence
microscopy using Axioplan II equipment (Zeiss, Germany).
Analysis of BKR expression by quantitative real-time PCR and ﬂow
cytometry
HBMECs (106 cells/well) were incubated with SINV (MOI of 0.1) in
its native or inactivated forms, or with mock control. After 24 h of
infection the cells were harvested and BK1R and BK2R transcription
and expression were analyzed by quantitative real-time PCR (qPCR)
and ﬂow cytometry, respectively. Total RNA was extracted from
HBMECs using the RNeasy mini Kit (Qiagen, Valencia, CA) and treated
with DNAse (Qiagen, Valencia, CA), according to manufacturer's in-
structions. Total RNA (1 μg) was reversely transcribed to cDNA using
SuperScript III First-strand Synthesis System (Invitrogen, Carlsbad, CA)
and random hexamer primers (Invitrogen, Carlsbad, CA) using follow-
ing parameters: 50 °C for 30 min, 85 °C for 5 min and chilled on ice.
Afterwards, RNaseH (2U) (Invitrogen, Carlsbad, CA) was added and
samples were incubated at 37 °C for 20 min. qPCR was carried outusing the ABI PRISM 7500 device (Applied Biosystems, Foster City,
CA). Human β-actin assay (Applied Biosystems, Foster City, CA) was
used for normalization due to its constitutive production in chosen
cells. The reactions were performed in triplicates and included 2 μl
of cDNA, BK1R or BK2R gene expression assays (TaqMan® gene expres-
sion assays— Applied Biosystems, Foster City, CA, USA), TaqMan Uni-
versal PCR Master Mix (Applied Biosystems, Foster City, CA) and
water added to a ﬁnal volume of 25 μl. Triplicates of non-template
controls (NTC) were always included in the reactions. Cycle condi-
tions were as follows: after an initial 2-min hold at 50 °C and
10 min at 95 °C, the samples were cycled 40 times at 95 °C for 15 s
and 60 °C for 1 min. Baseline and threshold for cycle threshold (Ct)
calculation were set automatically with Sequence Detection Software
version 1.4 (Applied Biosystems, Foster City, CA). The efﬁciency of
ampliﬁcation (E) of a target molecule was calculated from the slope of
the standard curve (plot of Ct vs the negative log10 concentration of
the target) derived from the slopes (E=[10(−1/Slope)]−1). For relative
calculation, the ΔΔCt method was used (Livak and Schmittgen 2001,
Applied Biosystems 7500/7500 Fast Real-Time PCR Systems — User
Bulletin) once all assays met the ampliﬁcation efﬁciency criteria of
100%±10% (Applied Biosystems — Application Note 127AP05-02).
To analyze the expression of BKR protein in the cells surface, the
cells were ﬁxed with 4% paraformaldehyde for 10 min and blocked
with PBS containing 2% normal mouse serum and 1% fetal calf
serum for 30 min. Rabbit anti-BK1R or anti-BK2R antibody (Santa Cruz
Biotechnology CA, EUA) were added and this treatment was followed
by incubation with anti-rabbit IgG antibody conjugated to PE (Invitro-
gen, Carlsbad, CA) to detect BKRs. The cells were then permeabilized
with 0.1% saponin and stained withmouse anti-SINV, followed by incu-
bation with anti-mouse IgG antibody conjugated Alexa ﬂuor-488 (Invi-
trogen, Carlsbad, CA). Samples were run in a FACSCalibur cytometer,
and data analyseswere performedusing the CellQuest software (Becton
Dickson Immunocytometry System).
Analysis of cell viability
Cell viability was evaluated by MTT metabolization measurement.
HBMECs (1.25×104/well) were inoculated with SINV (MOI of 0.1), in
its native or inactivated forms, or mock-infected. After different time
points post infection, the cells were incubated with 0.5 mg/ml MTT
for 2 h and the acid solution (0.04 M HCl in isopropanol) was
added. The absorbance was measured at 570 nm.
Analysis of apoptosis
HBMECs cells (106) were inoculated with SINV (MOI of 0.1) or
mock-infected. After 24 h p.i. the cells were stimulated with BK, in
the presence of the ACEi, lisinopril. After 12–24 h post stimuli
(36–48 h p.i.), the cells were washed with PBS, harvested in 100 μl
annexin buffer, and incubated with Alexa ﬂuor 488-annexin V and
propide iodide (PI) (Annexin V-FITC Apoptosis Detection Kit, Becton
Dickinson and Company, Franklin Lakes, NJ). After 15 min, the cells
were harvested in 400 μl of annexin V buffer. The proportion of live
(AnnexinV−/PI−), dead (AnnexinV−/PI+), or early and late apoptotic
cells (AnnexinV+/PI− and AnnexinV+/PI+) were evaluated by ﬂow
cytometry, using the FACScalibur equipment and CellQuest software
(Becton Dickson Immunocytometry System).
Alternatively, the apoptosis was measured by PI staining only,
after cell permeabilization. PI is a DNA intercalator and its staining in-
dicates the content of DNA in a given cell. Therefore, the amount of
sub-diploid apoptotic cells can be quantiﬁed by ﬂow cytometry.
HBMECs cells (1.25×104) were inoculated with SINV (MOI of 0.1)
or mock-infected. After 24 h p.i. the cells were stimulated with
ACEi/BK, in the presence or absence of HOE-140 (100 nM), wortman-
nin (100 nM) or PD 98059 (30 μM). After 12 h post stimuli (36 h p.i.)
the cells were detached with trypsin and harvested in 200 μl of the
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triton X-100, 50 μg/ml of the propidium iodide). The cells were incu-
bated for 1 h and the percentage of apoptotic cells was evaluated by
ﬂow cytometry.
Western blotting
HBMECs (106 cells/well) were inoculated with SINV (MOI of 0.1)
or mock-infected for the indicated periods of time. After 24 h p.i.
the cells were stimulated with BK, in the presence or absence of
HOE-140, wortmannin, or PD98059. Cells were washed with PBS
and lysed in lysis buffer (10 mM Tris–HCl pH 7.5; 5 mM de EDTA pH
8.0; 150 mM NaCl; 0.1% NP-40). Extracts were clariﬁed by centrifuga-
tion, and protein concentration was determined by the Bradford
assay (Bio-Rad DC Protein Assay). Lysates containing equal amounts
of protein were boiled with SDS sample buffer containing 2-
mercato-ethanol. Proteins were separated by SDS-PAGE and then
electro-transferred to nitrocellulose membranes (Thermo Fisher Sci-
entiﬁc Inc., Rockford, IL, USA), which were blocked in 5% bovine
serum albumin in Tris-buffered saline solution containing 0.1%
Tween-20. Primary antibodies were diluted according to the manu-
facturer's instructions and membranes incubated overnight at 4 °C
with pERK or pAKT (Cell Signalling, Danvers, MA, USA), and β-actin
or α-tubulin (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for nor-
malization. After washing, the membranes were incubated with
horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG an-
tibodies (Santa Cruz Biotechnology) and proteins were visualized
using ECL Western blotting detection systems (Super Signal® West
Pico Chemiluminescent Substrate Thermo Scientiﬁc), according
to the manufacturer's instructions. The ratio of phosphorylated
kinases/constitutive proteins was determined using the ScionImage
software.
In vivo infection
Male and female BALB/c mice with ages ranging from 4 to 6 weeks
were obtained from the animal facility of the Instituto de Microbiolo-
gia Prof. Paulo de Góes from Federal University of Rio de Janeiro. The
animals were bred and housed according to institutional policies for
animal care and usage. All experimental protocols were submitted
to the Ethical Committee from the Centro de Ciências da Saúde of Fed-
eral University of Rio de Janeiro. The mice were pretreated with the
ACE inhibitor captopril at 100 mg/kg (i.p.) and then inoculated intra-
cerebrally (i.c.) with 5×104 PFU of SINV, with or without HOE-140
(100 μg/kg). Control mice were inoculated with endotoxin-free medi-
um (vehicle). The animals were sacriﬁced 24 h p.i. and the brain was
removed and macerated in PBS. Brain extract was centrifuged and su-
pernatant was stored in −70° for later use. Virus-containing brain
suspensions were evaluated by plaque assay in VERO cells and nor-
malized by brain weight.
Statistical analysis
The mean and SD were calculated for each experimental group.
Differences between groups were analyzed by the Student's t test for
unpaired samples using the PRISM statistical analysis software
(GraphPadSoftware, Inc., San Diego, CA). Results with pb0.05 were
considered signiﬁcant.
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